Hepatitis A immune status (Anti-HAV IgG)

Useful For

Anti-HAV IgG is an indicator of successful HAV vaccination or indicator of prior HAV exposure.

 

 

Indications for Testing

Immune status determination

 

Reporting Name Available separately Always performed
Hepatitis A IgG YES YES

 

Special Instructions and Forms

HAV in a Provincial Notifiable disease. More information on Provincial vaccination and epidemiology can be found at HERE.

 

Method Name

IgG enzyme-linked immunosorbent assay (ELISA)

 

Reporting Name

Anti-HAV IgG

 

Aliases

Anti-HAV

Hepatitis A Virus

HAA

Hepatitis A Antibody

Jaundice

HAV

Hep A

Serology: Suitable specimens are individual samples (human sera or EDTA/heparinized/citrated plasma) obtained by standard laboratory techniques.

 

Specimen Minimum Volume

0.6ml

 

Transport Temperature

Specimen Room temperature Refrigerated Frozen
Serum NO YES* YES**

*The samples should be stored for not more than 3 days at 2-8°C.

**For longer delay, freeze at -70°C and transport on dry ice.

 

Reject Due To

Specimens other than Serum
Anticoagulants OK
Hemolysis OK
Lipemia OK
Icteric OK

 

Useful For

Anti-HAV IgG is an indicator of successful HAV vaccination or indicator of prior HAV exposure.

 

Clinical Information

Hepatitis A characteristically is an acute, self-limited illness associated with fever, malaise, jaundice, anorexia, and nausea. Among older children and adults, infection usually is symptomatic and typically lasts several weeks, with jaundice occurring in 70% or more. Symptomatic infection occurs in approximately 30% of infected children younger than 6 years of age; few of these children will have jaundice. Fulminate hepatitis is rare but is more common in people with underlying liver disease. Chronic infection does not occur.

 

Hepatitis A virus (HAV) is endemic throughout the world, occurring most commonly in areas of poor hygiene and low socioeconomic conditions. The virus is transmitted by the fecal-oral route, and it is spread by close person-to-person contact and by contaminated food and water. Thorough cooking is necessary to inactivate HAV in contaminated foods. Outbreaks frequently occur in overcrowded situations and in high-density institutions and centers, such as prisons and health care or day care centers. Viral spread by parenteral routes (eg, exposure to blood) is possible but rare, because infected individuals are viremic for a short period of time (usually <3 weeks). There is little or no evidence of transplacental transmission from mother to fetus or transmission to newborn during delivery.

 

HAV is a nonenveloped, positive-strand RNA virus of the Picornaviridae family, which includes the enteroviruses, parechoviruses, and rhinoviruses of humans, as well as the apthoviruses or hoofed animals and cardioviruses of mice. Although HAV shares general structure and genomic organization with the other picornaviruses, it has limited nucleotide sequence homology and distinguishing characteristics that have resulted in its being classified in its own genus, Hepatovirus.

 

Reference Values

Anti-HAV IgG

NONREACTIVE

 

Interpretation

·         Anti-HAV IgG RACTIVE result indicates current or previous remote exposure (natural or vaccination) to HAV.

·         Anti-HAV IgG NON-REACTIVE result indicates the absence of prior exposure to HAV and nonimmunity. However, a NON-REACTIVE result does not rule out HAV infection. The specimen may have been drawn before the appearance of detectable antibodies. NON-REACTIVE results in suspected early HAV infections should be followed by testing a new serum specimen.

 

Clinical Reference

Abbott. 2004. ARCHITECT System HAVAb-IgG: package insert. Abbott Diagnostics Division, Wiesbaden, Germany.

 

Anderson, D. A. 2007. Hepatitis A and E Viruses, p. 1424-1436. In Murray, P. R., Baron, E. J., Jorgensen, J. H., Landry, M. L., and Pfaller, M. A. Manual of Clinical Microbiology, 9th ed., vol. 2. ASM Press, American Society for Microbiology, Washington, DC.

 

Wasley, A., Feinstone, S. M, and Bell, B. P. 2010. Hepatitis A Virus, p. 2367-2387. In Mandell, D., Bennett, J. E., and Dolin, R. Principles and practice of infectious diseases, 7th ed., vol. 2. Churchill Livingstone, Elsevier, Philadelphia, PA.

 

Status Days Analytic Time Maximum Laboratory Time Specimen Retention
Routine Mon, Wed, Fri 7h 72h 1 month

 

Method Description

Enzyme-linked immunosorbent assay (ELISA)

 

Performing Laboratory Location

Newfoundland & Labrador Public Health Laboratory

St. John’s

 

 

Latest Updates


Website Downtime - August 14

Sep 30

Due to a datacenter upgrade on August 14, there will be a website outage from 1PM PST - 1AM PST or 5PM AST - 5AM AST. More »


Respiratory and COVID-19 Test Ordering Changes - July 17, 2020

Sep 30

More »

 

Newsletter Signup

Enter your email address below to receive important updates from our labs!